Biden dissolves Covid-19 panel that advised his transition – STAT
Biden disbanded the panel of doctors, researchers, and health experts that advised him through the transition.
Biden disbanded the panel of doctors, researchers, and health experts that advised him through the transition.
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
On May 8, join us for a conversation with practicing neurologists about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new…
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s…
A virtual-second model can have long-term benefits across the health care system, from improving patients’ experiences to growing the telehealth market.
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a…
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an injectable candidate that’s seen as a potential…
Whether or not the USPSTF says “B” or “C,” the goal is for women in their 40s to have informative conversations with their health care…
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
Check out the inaugural edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
The drug-pricing watchdogs over at the Institute for Clinical and Economic Review tend to be supportive of gene therapy pricing, even when the price is…